Literature DB >> 7504157

Isolation of Pseudomonas cepacia in cystic fibrosis patient.

E de A Marques1, R M Pinto, L T Dallallana, E F de Oliveira, I Suassuna.   

Abstract

Pulmonary infection on cystic fibrosis (CF) patients are associated with a limited qualitative number of microorganisms. During the colonization process, Staphylococcus aureus usually precedes Pseudomonas aeruginosa. This latter is at first non-mucoid, being replaced or associated to a mucoid morphotype which is rare in other diseases. In 1980, Pseudomonas cepacia appeared as an important agent in CF pulmonary infections with a mean frequency of about 6.1% isolations in different parts of the world. The primus colonization mainly occurs in the presence of pre-existent tissue lesions and the clinical progress of the disease is variable. In some patients it can be fulminant; in others it can cause a gradual and slow decrease in their pulmonary functions. The concern with this germ isolation is justified by its antibiotic multiple resistance and the possibility of direct transmission from a colonized patient to a non-colonized one. We reported the first case of P. cepacia infection in a CF patient in our area. The microbiological attendance to this patient had been made from 1986 to 1991 and the first positive culture appeared in 1988. The sensitivity profile showed that the primus colonization strain was sensitive to 9 of 17 tested antibiotics, however in the last culture the strain was resistant to all antibiotics. These data corroborate the need for monitoring the bacterial flora on CF patients respiratory system.

Entities:  

Mesh:

Year:  1993        PMID: 7504157     DOI: 10.1590/s0074-02761993000100019

Source DB:  PubMed          Journal:  Mem Inst Oswaldo Cruz        ISSN: 0074-0276            Impact factor:   2.743


  1 in total

1.  Valorization of date juice by the production of lipopeptide biosurfactants by a Bacillus mojavensis BI2 strain: bioprocess optimization by response surface methodology and study of surface activities.

Authors:  Inès Mnif; Amir Bouallegue; Salwa Mekki; Dhouha Ghribi
Journal:  Bioprocess Biosyst Eng       Date:  2021-07-09       Impact factor: 3.210

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.